Toxicological evaluation of μ‐agonists part I: Assessment of toxicity following 30 days of repeated oral dosing of male and female rats with levo‐alpha‐acetylmethadol HCl (LAAM)

J. Borzelleca,J. Egle,L. Harris,D. N. Johnson,J. B. Terrill,Jo Ann Nuite Belleville
DOI: https://doi.org/10.1002/jat.2550140609
Abstract:This study evaluated levo‐alpha‐acetylmethadol hydrochloride (LAAM), a long‐acting morphine‐like (μ) agonist approved in 1993 to treat opiate dependence. Sprague‐Dawley rate (20/sex/group) were gavaged with doses of 3.0–33.5 mg kg−1 for 30 days followed by a 14‐day drug‐free recovery period. Treatment‐related effects included dose‐dependent CNS depression, decreased food consumption and body weight gain, reddish urine and abdominal staining. Tolerance developed by day 7. Mortality was dose‐dependent; deaths occurred predominantly during the first week. Increased alanine aminotransferase (SGOT, AST) and lactate dehydrogenase (LDH), observed only in high‐dose males, were associated with findings in liver. Decreases in spleen/brain weight and increases in brain/body weight ratios were seen in both sexes. Decreases in weights of heart, liver and kidney achieved statistical significance only for high‐dose groups. Kidneys of mid‐ and high‐dose groups displayed intertubular mineral/crystal deposition, focal corticomedullary mineralization and focal regenerative tubular epithelium. Centrilobular hypertrophy was observed in livers of high‐dose males and mid‐ and high‐dose females. Following the recovery period, decreased body weights and increased brain/body weight ratios occurred in mid‐dose males and low‐dose females. Weights of liver and kidney and organ/brain weight ratios were decreased in mid‐dose males. Histopathological findings observed in kidneys and livers had abated.
What problem does this paper attempt to address?